Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis
CM O'Connor,
RM Califf,
EW Massey,
DB Mark,
DJ Kereiakes,
RJ Candela,
C Abbottsmith,
B George,
RS Stack,
L Aronson,
et al.
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Thirteen (1.8%) of 708 patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator in the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I, II and III trials developed a stroke. Four strokes were hemorrhagic and nine were nonhemorrhagic. Of five prespecified risk factors for intracranial hemorrhage (age greater than 65 years, history of hypertension, history of prior cerebrovascular disease, aspirin use and acute hypertension), two patients had two risk factors and one patient had one risk factor. However, 80% of patients without intracranial hemorrhage had at least one risk factor and 31% had two risk factors. No patient with a prior stroke or transient ischemic attack (all greater than 6 months previously) had an intracranial hemorrhage. Of three prespecified risk factors for nonhemorrhagic stroke (atrial fibrillation, prior cerebrovascular disease and large anterior wall infarction), only the occurrence of a large anterior myocardial infarction (with ejection fraction less than 45%) was a predictor (p = 0.0015). The in-hospital death rate was 25% for patients with hemorrhagic stroke versus 11% for patients with a non-hemorrhagic stroke and 6% for those patients without a stroke. Furthermore, the hospital stay was greater than 50% longer in patients who had a stroke than in those who did not. Thus, intracranial hemorrhage remains an unpredictable risk in patients treated with thrombolytic therapy and cerebral infarction is related to anterior myocardial infarction and poor left ventricular function. Both types of stroke are associated with substantial morbidity and mortality.
This article has been cited by other articles:
|
|
|
|
 
G. W. Stone
Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention
Circulation,
July 29, 2008;
118(5):
538 - 551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Witt, R. D. Brown Jr., S. J. Jacobsen, S. A. Weston, B. P. Yawn, and V. L. Roger
A Community-Based Study of Stroke Incidence after Myocardial Infarction
Ann Intern Med,
December 6, 2005;
143(11):
785 - 792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Budaj, K. Flasinska, J. M. Gore, F. A. Anderson Jr, O. H. Dabbous, F. A. Spencer, R. J. Goldberg, K. A.A. Fox, and for the GRACE Investigators
Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes: Findings From a Global Registry of Acute Coronary Events
Circulation,
June 21, 2005;
111(24):
3242 - 3247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Savonitto, P.W. Armstrong, A.M. Lincoff, G. Jia, C.A. Sila, J. Booth, P. Terrosu, C. Cavallini, H.D. White, D. Ardissino, et al.
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction: Dichotomous response as a function of age in the GUSTO V trial
Eur. Heart J.,
October 2, 2003;
24(20):
1807 - 1814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Stenestrand and L. Wallentin
Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment-Elevation Myocardial Infarction: One-Year Follow-up of a Large Prospective Cohort
Arch Intern Med,
April 28, 2003;
163(8):
965 - 971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cronin, S. R. Mehta, F. Zhao, J. Pogue, A. Budaj, D. Hunt, and S. Yusuf
Stroke in Relation to Cardiac Procedures in Patients With Non-ST-Elevation Acute Coronary Syndrome: A Study Involving >18 000 Patients
Circulation,
July 17, 2001;
104(3):
269 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. W. Mahaffey, R. A. Harrington, M. L. Simoons, C. B. Granger, C. Graffagnino, M. J. Alberts, D. T. Laskowitz, J. M. Miller, M. A. Sloan, L. G. Berdan, et al.
Stroke in Patients With Acute Coronary Syndromes : Incidence and Outcomes in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
Circulation,
May 11, 1999;
99(18):
2371 - 2377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Trouillas, N. Nighoghossian, L. Derex, P. Adeleine, J. Honnorat, P. Neuschwander, G. Riche, J.-C. Getenet, W. Li, J.-C. Froment, et al.
Thrombolysis With Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke : Determination of Etiological, Topographic, and Radiological Outcome Factors
Stroke,
December 1, 1998;
29(12):
2529 - 2540.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tanne, S. Gottlieb, A. Caspi, H. Hod, A. Palant, L. Reisin, T. Rosenfeld, B. Peled, A. T. Marmor, J. Balkin, et al.
Treatment and Outcome of Patients With Acute Myocardial Infarction and Prior Cerebrovascular Events in the Thrombolytic Era: The Israeli Thrombolytic National Survey
Arch Intern Med,
March 23, 1998;
158(6):
601 - 606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. W. Mahaffey, C. B. Granger, M. A. Sloan, T. D. Thompson, J. M. Gore, W. D. Weaver, H. D. White, M. L. Simoons, G. I. Barbash, E. J. Topol, et al.
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis : Results From GUSTO-I
Circulation,
March 3, 1998;
97(8):
757 - 764.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Gore, C. B. Granger, M. L. Simoons, M. A. Sloan, W. D. Weaver, H. D. White, G. I. Barbash, F. Van de Werf, P. E. Aylward, E. J. Topol, et al.
Stroke After Thrombolysis : Mortality and Functional Outcomes in the GUSTO-I Trial
Circulation,
November 15, 1995;
92(10):
2811 - 2818.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. T. Vaitkus
Left Ventricular Mural Thrombus and the Risk of Embolic Stroke after Acute Myocardial Infarction
European Journal of Cardiovascular Prevention & Rehabilitation,
April 1, 1995;
2(2):
103 - 106.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. W. Wyble, V. D. Karabinis, and M. D. Kerstein
Intracranial Hemorrhage as the Synergistic Effect of Urokinase and Renal Dysfunction--A Case Report
Vascular and Endovascular Surgery,
June 1, 1993;
27(5):
395 - 399.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. Doorey, E. L. Michelson, and E. J. Topol
Thrombolytic Therapy of Acute Myocardial Infarction: Keeping the Unfulfilled Promises
JAMA,
December 2, 1992;
268(21):
3108 - 3114.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. T. Vaitkus, J. A. Berlin, J. S. Schwartz, and E. S. Barnathan
Stroke Complicating Acute Myocardial Infarction: A Meta-analysis of Risk Modification by Anticoagulation and Thrombolytic Therapy
Arch Intern Med,
October 1, 1992;
152(10):
2020 - 2024.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. H. Gurwitz, R. J. Goldberg, and J. M. Gore
Coronary Thrombolysis for the Elderly?
JAMA,
April 3, 1991;
265(13):
1720 - 1723.
[Abstract]
[PDF]
|
|
|
|
